View Webinar (Jointly provided by SNMMI, July 2019)*

Speakers: Daniel Pryma, MD, University of Pennsylvania; and Amanda Abbott, MS, CNMT, RT(N)(CT), PET, Dana-Farber Cancer Institute

Learning Objectives:

  1. Understand the regulatory considerations for the administration of 177Lu-DOTATATE
  2. Appreciate the logistical considerations and space planning for treatment
  3. Understand the adjunctive medication options and their appropriate utilization

 Credit type/Info: AMA, SAM, VOICE